“Ketorolac on Posterior Thoracolumbar Spinal Fusions”
To determine is low-dose ketorolac use in the early post-operative period (within 48 hours) provides adequate analgesia without long term adverse effect on spinal fusion rates when compared to post-operative analgesia without the use of NSAIDs.
Drug - Saline
1 ml saline IV Q6H
Drug - Ketorolac
15 mg (15 mg/ml) IV Q6H
The Effect of Ketorolac on Posterior Thoracolumbar Spinal Fusions: a Prospective Randomized Controlled Trial